{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T12:30:07Z","timestamp":1788957007825,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T00:00:00Z","timestamp":1673913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T00:00:00Z","timestamp":1673913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870486"],"award-info":[{"award-number":["81870486"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070732"],"award-info":[{"award-number":["82070732"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82090021"],"award-info":[{"award-number":["82090021"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-023-03467-7","type":"journal-article","created":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T13:03:22Z","timestamp":1673960602000},"page":"1565-1574","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Long-term visit-to-visit variability in low-density lipoprotein cholesterol is associated with poor cardiovascular and kidney outcomes in patients with primary nephrotic syndrome"],"prefix":"10.1007","volume":"55","author":[{"given":"Xuan","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Miao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Qiang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Yang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Hui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,17]]},"reference":[{"issue":"6","key":"3467_CR1","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/ki.2014.31","volume":"85","author":"C Wanner","year":"2014","unstructured":"Wanner C, Tonelli M, Kidney Disease: Improving Global Outcomes Lipid Guideline Development Work Group Members (2014) KDIGO clinical practice guideline for lipid management in CKD: summary of recommendation statements and clinical approach to the patient. Kidney Int 85(6):1303\u20131309. https:\/\/doi.org\/10.1038\/ki.2014.31","journal-title":"Kidney Int"},{"issue":"4S","key":"3467_CR2","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","volume":"100","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group","year":"2021","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group (2021) KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int 100(4S):S1\u2013S276. https:\/\/doi.org\/10.1016\/j.kint.2021.05.021","journal-title":"Kidney Int"},{"issue":"3","key":"3467_CR3","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/kisup.2013.27","volume":"3","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group","year":"2013","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group (2013) KDIGO clinical practice guideline for lipid management in chronic kidney disease. Kidney Int Suppl 3(3):259\u2013305. https:\/\/doi.org\/10.1038\/kisup.2013.27","journal-title":"Kidney Int Suppl"},{"issue":"12","key":"3467_CR4","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41581-018-0072-9","volume":"14","author":"CJ Ferro","year":"2018","unstructured":"Ferro CJ, Mark PB, Kanbay M, Sarafidis P, Heine GH, Rossignol P, Massy ZA, Mallamaci F, Valdivielso JM, Malyszko J, Verhaar MC, Ekart R, Vanholder R, London G, Ortiz A, Zoccali C (2018) Lipid management in patients with chronic kidney disease. Nat Rev Nephrol 14(12):727\u2013749","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"3467_CR5","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/s0270-9295(03)00058-5","volume":"23","author":"TL Nickolas","year":"2003","unstructured":"Nickolas TL, Radhakrishnan J, Appel GB (2003) Hyperlipidemia and thrombotic complications in patients with membranous nephropathy. Semin Nephrol 23(4):406\u2013411. https:\/\/doi.org\/10.1016\/s0270-9295(03)00058-5","journal-title":"Semin Nephrol"},{"issue":"1","key":"3467_CR6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.cell.2015.01.036","volume":"161","author":"JL Goldstein","year":"2015","unstructured":"Goldstein JL, Brown MS (2015) A Century of cholesterol and coronaries: from plaques to genes to statins. Cell 161(1):161\u2013172. https:\/\/doi.org\/10.1016\/j.cell.2015.01.036","journal-title":"Cell"},{"issue":"6","key":"3467_CR7","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1053\/j.ajkd.2015.06.028","volume":"66","author":"AB Reiss","year":"2015","unstructured":"Reiss AB, Voloshyna I, De Leon J, Miyawaki N, Mattana J (2015) Cholesterol metabolism in CKD. Am J Kidney Dis 66(6):1071\u20131082. https:\/\/doi.org\/10.1053\/j.ajkd.2015.06.028","journal-title":"Am J Kidney Dis"},{"issue":"9784","key":"3467_CR8","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","volume":"377","author":"C Baigent","year":"2011","unstructured":"Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C et al (2011) The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet 377(9784):2181\u20132192. https:\/\/doi.org\/10.1016\/S0140-6736(11)60739-3","journal-title":"Lancet"},{"issue":"48","key":"3467_CR9","doi-asserted-by":"publisher","first-page":"3560","DOI":"10.1093\/eurheartj\/ehx585","volume":"38","author":"MK Kim","year":"2017","unstructured":"Kim MK, Han K, Kim HS, Park YM, Kwon HS, Yoon KH, Lee SH (2017) Cholesterol variability and the risk of mortality, myocardial infarction, and stroke: a nationwide population-based study. Eur Heart J 38(48):3560\u20133566. https:\/\/doi.org\/10.1093\/eurheartj\/ehx585","journal-title":"Eur Heart J"},{"issue":"23","key":"3467_CR10","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1161\/CIRCULATIONAHA.118.034978","volume":"138","author":"MK Kim","year":"2018","unstructured":"Kim MK, Han K, Park YM, Kwon HS, Kang G, Yoon KH, Lee SH (2018) Associations of variability in blood pressure, glucose and cholesterol concentrations, and body mass index with mortality and cardiovascular outcomes in the general population. Circulation 138(23):2627\u20132637. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.034978","journal-title":"Circulation"},{"issue":"24","key":"3467_CR11","doi-asserted-by":"publisher","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","volume":"73","author":"SM Grundy","year":"2019","unstructured":"Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC Jr, Sperling L, Virani SS, Yeboah J (2019) 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the american college of cardiology\/american heart association task force on clinical practice guidelines. J Am Coll Cardiol 73(24):e285\u2013e350. https:\/\/doi.org\/10.1016\/j.jacc.2018.11.003","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"3467_CR12","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.015359","volume":"9","author":"Wang Q, Wang Y, Wang J, Zhang L, Zhao MH; C-STRIDE (Chinese Cohort Study of Chronic Kidney Disease)","year":"2020","unstructured":"Wang Q, Wang Y, Wang J, Zhang L, Zhao MH; C-STRIDE (Chinese Cohort Study of Chronic Kidney Disease) (2020) Short-term systolic blood pressure variability and kidney disease progression in patients with chronic kidney disease: results from C-STRIDE. J Am Heart Assoc 9(12):e15359. https:\/\/doi.org\/10.1161\/JAHA.120.015359","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"3467_CR13","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/ki.2010.462","volume":"79","author":"LA Stevens","year":"2011","unstructured":"Stevens LA, Claybon MA, Schmid CH, Chen J, Horio M, Imai E, Nelson RG, Van Deventer M, Wang HY, Zuo L, Zhang YL, Levey AS (2011) Evaluation of the chronic kidney disease epidemiology collaboration equation for estimating the glomerular filtration rate in multiple ethnicities. Kidney Int 79(5):555\u2013562. https:\/\/doi.org\/10.1038\/ki.2010.462","journal-title":"Kidney Int"},{"issue":"1","key":"3467_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrneph.2017.155","volume":"14","author":"S Agrawal","year":"2018","unstructured":"Agrawal S, Zaritsky JJ, Fornoni A, Smoyer WE (2018) Dyslipidaemia in nephrotic syndrome: mechanisms and treatment. Nat Rev Nephrol 14(1):57\u201370. https:\/\/doi.org\/10.1038\/nrneph.2017.155","journal-title":"Nat Rev Nephrol"},{"issue":"18","key":"3467_CR15","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1001\/jama.2009.1619","volume":"302","author":"ERF Collaboration","year":"2009","unstructured":"Collaboration ERF, Di Angelantonio E, Sarwar N, Perry P, Kaptoge S, Ray KK, Thompson A, Wood AM, Lewington S, Sattar N, Packard CJ, Collins R, Thompson SG, Danesh J (2009) Major lipids, apolip oproteins, and risk of vascular disease. JAMA 302(18):1993\u20132000. https:\/\/doi.org\/10.1001\/jama.2009.1619","journal-title":"JAMA"},{"issue":"3","key":"3467_CR16","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.ccl.2021.04.008","volume":"39","author":"A Thobani","year":"2021","unstructured":"Thobani A, Jacobson TA (2021) Dyslipidemia in patients with kidney disease. Cardiol Clin 39(3):353\u2013363. https:\/\/doi.org\/10.1016\/j.ccl.2021.04.008","journal-title":"Cardiol Clin"},{"issue":"4","key":"3467_CR17","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.kint.2015.12.034","volume":"89","author":"B Bowe","year":"2016","unstructured":"Bowe B, Xie Y, Xian H, Balasubramanian S, Al-Aly Z (2016) Low levels of high-density lipoprotein cholesterol increase the risk of incident kidney disease and its progression. Kidney Int 89(4):886\u2013896. https:\/\/doi.org\/10.1016\/j.kint.2015.12.034","journal-title":"Kidney Int"},{"issue":"1","key":"3467_CR18","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s12882-020-01907-5","volume":"21","author":"X Liang","year":"2020","unstructured":"Liang X, Ye M, Tao M, Zheng D, Cai R, Zhu Y, Jin J, He Q (2020) The Association between dyslipidemia and the incidence of chronic kidney disease in the general zhejiang population: a retrospective study. BMC Nephrol 21(1):252. https:\/\/doi.org\/10.1186\/s12882-020-01907-5","journal-title":"BMC Nephrol"},{"issue":"7","key":"3467_CR19","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.2215\/CJN.09320913","volume":"9","author":"M Rahman","year":"2014","unstructured":"Rahman M, Yang W, Akkina S, Alper A, Anderson AH, Appel LJ, He J, Raj DS, Schelling J, Strauss L, Teal V, Rader DJ, CRIC Study Investigators (2014) Relation of Serum lipids and lipoproteins with progression of Ckd: the CRIC study. Clin J Am Soc Nephrol 9(7):1190\u20131198. https:\/\/doi.org\/10.2215\/CJN.09320913","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"3467_CR20","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1046\/j.1523-1755.2000.00165.x","volume":"58","author":"P Muntner","year":"2000","unstructured":"Muntner P, Coresh J, Smith JC, Eckfeldt J, Klag MJ (2000) Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int 58(1):293\u2013301. https:\/\/doi.org\/10.1046\/j.1523-1755.2000.00165.x","journal-title":"Kidney Int"},{"issue":"15","key":"3467_CR21","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1016\/j.jacc.2015.02.017","volume":"65","author":"S Bangalore","year":"2015","unstructured":"Bangalore S, Breazna A, Demicco DA, Wun CC, Messerli FH, TNT steering committee and investigators (2015) Visit-to-visit low-density lipoprotein cholesterol variability and risk of cardiovascular outcomes: insights from the TNT trial. J Am Coll Cardiol 65(15):1539\u20131548. https:\/\/doi.org\/10.1016\/j.jacc.2015.02.017","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"3467_CR22","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.amjcard.2016.10.037","volume":"119","author":"S Bangalore","year":"2017","unstructured":"Bangalore S, Fayyad R, Messerli FH, Laskey R, DeMicco DA, Kastelein JJ, Waters DD (2017) Relation of variability of low-density lipoprotein cholesterol and blood pressure to events in patients with previous myocardial infarction from the IDEAL trial. Am J Cardiol 119(3):379\u2013387. https:\/\/doi.org\/10.1016\/j.amjcard.2016.10.037","journal-title":"Am J Cardiol"},{"issue":"3","key":"3467_CR23","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.18632\/oncotarget.23228","volume":"9","author":"YH Lin","year":"2017","unstructured":"Lin YH, Huang JC, Wu PY, Chen SC, Chiu YW, Chang JM, Chen HC (2017) Greater low-density lipoprotein cholesterol variability is associated with increased progression to dialysis in patients with chronic kidney disease stage. Oncotarget 9(3):3242\u20133253.\u00a0https:\/\/doi.org\/10.18632\/oncotarget.23228","journal-title":"Oncotarget"},{"issue":"11","key":"3467_CR24","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1111\/dom.12976","volume":"19","author":"A Ceriello","year":"2017","unstructured":"Ceriello A, De Cosmo S, Rossi MC, Lucisano G, Genovese S, Pontremoli R, Fioretto P, Giorda C, Pacilli A, Viazzi F, Russo G, Nicolucci A, AMD-Annals Study Group (2017) Variability in HbA1c, blood pressure, lipid parameters and serum uric acid, and risk of development of chronic kidney disease in type 2 diabetes. Diabetes Obes Metab 19(11):1570\u20131578. https:\/\/doi.org\/10.1111\/dom.12976","journal-title":"Diabetes Obes Metab"},{"issue":"10","key":"3467_CR25","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1161\/ATVBAHA.117.309803","volume":"37","author":"MK Kim","year":"2017","unstructured":"Kim MK, Han K, Koh ES, Kim HS, Kwon HS, Park YM, Yoon KH, Lee SH (2017) Variability in total cholesterol is associated with the risk of end-stage renal disease: a nationwide population-based study. Arterioscler Thromb Vasc Biol 37(10):1963\u20131970. https:\/\/doi.org\/10.1161\/ATVBAHA.117.309803","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"20","key":"3467_CR26","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1016\/j.jacc.2019.02.063","volume":"73","author":"FH Messerli","year":"2019","unstructured":"Messerli FH, Hofstetter L, Rimoldi SF, Rexhaj E, Bangalore S (2019) Risk factor variability and cardiovascular outcome: JACC review topic of the week. J Am Coll Cardiol 73(20):2596\u20132603. https:\/\/doi.org\/10.1016\/j.jacc.2019.02.063","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"3467_CR27","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1136\/heartjnl-2014-305623","volume":"100","author":"H Marti-Soler","year":"2014","unstructured":"Marti-Soler H, Gubelmann C, Aeschbacher S, Alves L, Bobak M, Bongard V et al (2014) Seasonality of cardiovascular risk factors: an analysis including over 230000 participants in 15 countries. Heart 100(19):1517\u20131523. https:\/\/doi.org\/10.1136\/heartjnl-2014-305623","journal-title":"Heart"},{"issue":"10","key":"3467_CR28","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.amjcard.2013.01.297","volume":"111","author":"DM Mann","year":"2013","unstructured":"Mann DM, Glazer NL, Winter M, Paasche-Orlow MK, Muntner P, Shimbo D, Adams WG, Kressin NR, Zhang Y, Choi H, Cabral H (2013) A pilot study identifying statin nonadherence with visit-to-visit variability of low-density lipoprotein cholesterol. Am J Cardiol 111(10):1437\u20131442. https:\/\/doi.org\/10.1016\/j.amjcard.2013.01.297","journal-title":"Am J Cardiol"},{"issue":"4","key":"3467_CR29","doi-asserted-by":"publisher","first-page":"310","DOI":"10.14740\/jocmr2871w","volume":"9","author":"A Takenouchi","year":"2017","unstructured":"Takenouchi A, Tsuboi A, Kitaoka K, Minato S, Kurata M, Fukuo K, Kazumi T (2017) Visit-to-visit low-density lipoprotein cholesterol variability is an independent determinant of carotid intima-media thickness in patients with Type 2 diabetes. J Clin Med Res 9(4):310\u2013316.\u00a0https:\/\/doi.org\/10.14740\/jocmr2871w","journal-title":"J Clin Med Res"},{"issue":"2","key":"3467_CR30","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jacl.2018.01.001","volume":"12","author":"RAJ Smit","year":"2018","unstructured":"Smit RAJ, Jukema JW, Postmus I, Ford I, Slagboom PE, Heijmans BT, Le Cessie S, Trompet S (2018) Visit-to-visit lipid variability: clinical significance, effects of lipid-lowering treatment, and (Pharmaco) genetics. J Clin Lipidol 12(2):266\u2013276. https:\/\/doi.org\/10.1016\/j.jacl.2018.01.001","journal-title":"J Clin Lipidol"},{"issue":"1","key":"3467_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.kint.2016.02.026","volume":"90","author":"ND Vaziri","year":"2016","unstructured":"Vaziri ND (2016) Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences. Kidney Int 90(1):41\u201352. https:\/\/doi.org\/10.1016\/j.kint.2016.02.026","journal-title":"Kidney Int"},{"issue":"1","key":"3467_CR32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nrneph.2015.180","volume":"12","author":"ND Vaziri","year":"2016","unstructured":"Vaziri ND (2016) HDL abnormalities in nephrotic syndrome and chronic kidney disease. Nat Rev Nephrol 12(1):37\u201347. https:\/\/doi.org\/10.1038\/nrneph.2015.180","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"3467_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1161\/CIRCULATIONAHA.115.020912","volume":"134","author":"ME Haas","year":"2016","unstructured":"Haas ME, Levenson AE, Sun X, Liao WH, Rutkowski JM, de Ferranti SD, Schumacher VA, Scherer PE, Salant DJ, Biddinger SB (2016) The role of proprotein convertase subtilisin\/kexin type 9 in nephrotic syndrome-associated hypercholesterolemia. Circulation 134(1):61\u201372. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.020912","journal-title":"Circulation"},{"issue":"2","key":"3467_CR34","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1677\/JOE-08-0054","volume":"197","author":"DP Macfarlane","year":"2008","unstructured":"Macfarlane DP, Forbes S, Walker BR (2008) Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome. J Endocrinol 197(2):189\u2013204. https:\/\/doi.org\/10.1677\/JOE-08-0054","journal-title":"J Endocrinol"},{"issue":"5","key":"3467_CR35","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1097\/00007890-200203150-00021","volume":"73","author":"F Vincenti","year":"2002","unstructured":"Vincenti F, Jensik SC, Filo RS, Miller J, Pirsch J (2002) A Long-Term comparison of tacrolimus (fk506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years. Transplantation 73(5):775\u2013782. https:\/\/doi.org\/10.1097\/00007890-200203150-00021","journal-title":"Transplantation"},{"issue":"4","key":"3467_CR36","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1161\/CIRCULATIONAHA.110.940932","volume":"122","author":"F Perticone","year":"2010","unstructured":"Perticone F, Maio R, Perticone M, Sciacqua A, Shehaj E, Naccarato P, Sesti G (2010) Endothelial dysfunction and subsequent decline in glomerular filtration rate in hypertensive patients. Circulation 122(4):379\u2013384. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.940932","journal-title":"Circulation"},{"issue":"2","key":"3467_CR37","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJM199901143400207","volume":"340","author":"R Ross","year":"1999","unstructured":"Ross R (1999) Atherosclerosis\u2013an inflammatory disease. N Engl J Med 340(2):115\u2013126. https:\/\/doi.org\/10.1056\/NEJM199901143400207","journal-title":"N Engl J Med"},{"issue":"27","key":"3467_CR38","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1093\/eurheartj\/ehy348","volume":"39","author":"F Alfonso","year":"2018","unstructured":"Alfonso F, Rivero F, S\u00e1nchez-Madrid F (2018) Variability in atherogenic lipoproteins and coronary artery disease progression. Eur Heart J 39(27):2559\u20132561. https:\/\/doi.org\/10.1093\/eurheartj\/ehy348","journal-title":"Eur Heart J"},{"issue":"3","key":"3467_CR39","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/MNH.0000000000000112","volume":"24","author":"M Eom","year":"2015","unstructured":"Eom M, Hudkins KL, Alpers CE (2015) Foam cells and the pathogenesis of kidney disease. Curr Opin Nephrol Hypertens 24(3):245\u2013251. https:\/\/doi.org\/10.1097\/MNH.0000000000000112","journal-title":"Curr Opin Nephrol Hypertens"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-023-03467-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-023-03467-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-023-03467-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T15:53:15Z","timestamp":1684165995000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-023-03467-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,17]]},"references-count":39,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["3467"],"URL":"https:\/\/doi.org\/10.1007\/s11255-023-03467-7","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,17]]},"assertion":[{"value":"28 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"All procedures involving human participants were approved by the Ethics Committee of Peking University First Hospital and complied with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}